Group 1 - The core point of the article highlights the transfer of shares of Minxin Group (00222) from Citic Bank International to Luk Fook Securities (Hong Kong), with a market value of HKD 143 million, representing 7.39% of the total shares [1] - Minxin Group reported its interim results for the fiscal year 2025, achieving a revenue of HKD 124 million, which is an increase of 1.98% year-on-year [1] - The net profit for Minxin Group reached HKD 64.868 million, reflecting a significant year-on-year increase of 94.85% [1] - The basic earnings per share for Minxin Group stood at HKD 0.1086 [1]

Core Viewpoint - Minxin Group (00222) has shown significant growth in its financial performance for the 2025 interim results, with a notable increase in net profit and a strategic shareholder transfer of stock [1] Group 1: Shareholder Activity - On November 12, Minxin Group's shares were transferred from Citic Bank International to Luxshare Securities (Hong Kong), with a total market value of HKD 143 million, representing 7.39% of the company [1] Group 2: Financial Performance - For the 2025 interim results, Minxin Group reported operating revenue of HKD 124 million, reflecting a year-on-year increase of 1.98% [1] - The net profit for the same period reached HKD 64.868 million, marking a substantial year-on-year increase of 94.85% [1] - The basic earnings per share were reported at HKD 0.1086 [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年10月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 閩信集團有限公司 | | | 呈交日期: | 2025年11月3日 | | | I. 法定/註冊股本變動 | 不適用 | | FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00222 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 597,257,252 | | 0 | | 597,257,252 | | 增加 / 減少 (-) | | | | | | | ...

Core Viewpoint - Yuyue Medical, a leading home respiratory device manufacturer, reported a mixed performance in its Q3 financial results, showing revenue growth but a significant decline in net profit [2][4]. Financial Performance - In Q3, Yuyue Medical achieved revenue of 1.886 billion yuan, a year-on-year increase of 9.63%, while net profit fell by nearly 36% to 263 million yuan [2]. - For the first three quarters, the company reported revenue of 6.545 billion yuan, up 8.58% year-on-year, but net profit decreased by 4.28% to 1.466 billion yuan [2]. Expense Analysis - The company experienced a substantial increase in sales expenses, which rose by 33.15% year-on-year to 1.232 billion yuan for the first three quarters, accounting for nearly one-fifth of total revenue [4]. - In Q3 alone, sales expenses reached 420 million yuan, a 33.3% increase, representing 22.2% of the quarterly revenue [4]. - Management and R&D expenses also saw an uptick, attributed to increased investments in R&D, brand building, and global network expansion [4][5]. Strategic Focus - Yuyue Medical's management emphasized three strategic directions for increased expenses: R&D investment, domestic and international brand development, and global network expansion [4][5]. - The company is focusing on digital and wearable product development and enhancing its talent acquisition for R&D [4]. - In Southeast Asia, particularly Thailand, the company is seeing strong revenue growth and plans to replicate its localized approach in other markets like Indonesia and Vietnam [5]. Market Outlook - The company faces rising labor and material costs, which are expected to continue impacting future operations [5]. - There are concerns regarding the company's ability to maintain double-digit revenue growth, with current valuations around 20 times earnings being considered high [6].

Group 1 - Citychamp Watch & Jewellery Group Limited reduced its stake in Minxin Group (00222) by selling 1.2 million shares at an average price of HKD 3.01 per share, totaling HKD 3.612 million [1] - After the reduction, Citychamp's latest shareholding stands at 89.37 million shares, representing a holding percentage of 14.96% [1]

Group 1 - Citychamp Watch & Jewellery Group Limited reduced its stake in Minxin Group (00222) by 1.2 million shares at an average price of HKD 3.01 per share, totaling HKD 3.612 million [1] - After the transaction, Citychamp's latest shareholding is 89.37 million shares, representing a 14.96% ownership stake [1] - The transaction involved other related parties, including Full Day Limited, Sincere View International Ltd., Lin Shuying, and Han Guolong [1]

Core Viewpoint - Citychamp Watch & Jewellery Group Limited has reduced its stake in Minxin Group (00222) by selling 1.2 million shares at an average price of HKD 3.01 per share, totaling HKD 3.612 million, resulting in a new holding of 89.37 million shares, representing 14.96% of the company [1] Group 1 - Citychamp Watch & Jewellery Group Limited sold 1.2 million shares of Minxin Group on October 20 [1] - The average selling price per share was HKD 3.01, leading to a total transaction amount of HKD 3.612 million [1] - After the sale, Citychamp's remaining shares in Minxin Group are 89.37 million, which corresponds to a 14.96% ownership stake [1] Group 2 - The transaction involved other related parties, including Full Day Limited, Sincere View International Ltd., Lin Shuying, and Han Guolong [1]

FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00222 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 597,257,252 | | 0 | | 597,257,252 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 597,257,252 | | 0 | | 597,257,252 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 閩信集團有限公司 | | | 呈交日期: | 2025年10月3日 | | ...

Yours faithfully, For and on behalf of Min Xin Holdings Limited Tse Ching Wah Company Secretary Encl. Notes: NOTIFICATION LETTER 通知信函 9 September 2025 To Non-registered Holders Note 1 Dear Sir/Madam, Notification of Publication of the Current Corporate Communication Min Xin Holdings Limited (the "Company") hereby notifies you that 2025 Interim Report (the "Current Corporate Communication"), in both English and Chinese versions, is available on the Company's website at www.minxin.com.hk and the website of Th ...

NOTIFICATION LETTER 通知信函 9 September 2025 Dear Shareholders Min Xin Holdings Limited (the "Company") — Notice of Publication of 2025 Interim Report (the "Current Corporate Communication") English and Chinese versions of the Current Corporate Communication are available under the Investor Information section of the Company's website at www.minxin.com.hk and the website of The Stock Exchange of Hong Kong Limited at www.hkexnews.hk (the "HKEXnews website"), or where applicable, the printed form of the Current ...